title: Serotonin-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue culture.
abstract: The effects of serotonin (5-hydroxytryptamine; 5-HT) on vasopressin (VP) and oxytocin (OT) secretion were studied in 13-14-day cultures of isolated rat neurohypophyseal (NH) tissue. The VP and OT contents of the supernatant were determined by radioimmunoassay after a 1 or 2 h incubation. Significantly increased levels of VP and OT production were detected in the tissue culture media following 5-HT administration, depending on the 5-HT dose. The elevation of NH hormone secretion could be partially blocked by previous administration of the 5-HT antagonist ketanserin or metergoline. WAY-100635 did not influence the increased VP secretion induced by 5-HT, but the elevated OT production was prevented by WAY-100635 before 5-HT administration. The application of WAY-100635, ketanserin or metergoline, after 5-HT administration proved ineffective. The results indicate that NH hormone release is influenced directly by the serotonergic system. The serotonergic control of VP and OT secretion from the NH tissue in rats can occur at the level of the posterior pituitary.
authors.affiliation: Department of Biology, Faculty of Juhász Gyula Teachers Training College, University of Szeged, Szeged, Hungary.
authors.forename: M
authors.initials: M
authors.lastname: Gálfi
authors.forename: M
authors.initials: M
authors.lastname: Radács
authors.forename: A
authors.initials: A
authors.lastname: Juhász
authors.forename: F
authors.initials: F
authors.lastname: László
authors.forename: A
authors.initials: A
authors.lastname: Molnár
authors.forename: F A
authors.initials: FA
authors.lastname: László
mesh_terms: D000818:Animals; D007650:Ketanserin / Q000378:metabolism / Q000494:pharmacology; D008297:Male; D008711:Metergoline / Q000378:metabolism / Q000494:pharmacology; D010121:Oxytocin / Q000378:metabolism*; D010879:Piperazines / Q000378:metabolism / Q000494:pharmacology; D010904:Pituitary Gland, Posterior / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D011725:Pyridines / Q000378:metabolism / Q000494:pharmacology; D011863:Radioimmunoassay; D051381:Rats; D017208:Rats, Wistar; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000378:metabolism / Q000494:pharmacology; D013997:Time Factors; D046509:Tissue Culture Techniques; D014667:Vasopressins / Q000378:metabolism*
chemical_list: D010879:Piperazines; D011725:Pyridines; D012702:Serotonin Antagonists; D014667:Vasopressins; D008711:Metergoline; D012701:Serotonin; D010121:Oxytocin; C090413:N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide; D007650:Ketanserin